The use of preoperative Breast MRI detects otherwise occult cancer with a relatively high degree of accuracy when applied to a diverse population of patients newly diagnosed with breast cancer, according to a study in the January issue of the Americ…
SEATTLE — Try to schedule your screening mammogram during the first week of your menstrual cycle. It might make breast cancer screening more accurate for pre-menopausal women who choose to have regular mammograms. This recommendation comes from an …
PHILADELPHIA — Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especi…
A new study suggests that the use of combination hormone therapy is associated with a modest increase in breast density, which is a known risk factor for breast cancer. The findings appear in the Jan. 1 issue of the Journal of the National Cancer Institute. The degree of breast-cancer risk that is associated with breast density is greater than that associated with almost all other known breast-cancer risk factors. A previous analysis of data from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, a randomized trial looking at the effects of postmenopausal hormone therapy (estrogen alone or estrogen plus three different progestin regimens) on breast density, showed that some women who used combination estrogen/progestin therapy experienced an increase in breast density. However, the analysis did not look at the magnitude of that increase.